Counterfeit Drugs Harm Real People
We're Collecting Their Stories
Protecting the safety of America's drug supply is about protecting human life. When we compromise the security of America's drug supply, we endanger patients. Sometimes people forget that these policy debates affect real people, but we at PSM never do.
In March 2002, oncology nurses in Missouri at discovered that their patient, Maxine Blount, had been taking Procrit that was only one-twentieth the strength it should have been. The counterfeit did not treat her anemia, leading to delays between chemotherapy infusions that allowed her cancer to advance much more rapidly. She died in October 2002.
In 2005, her brother testified before Congress: if her drugs had been genuine “she would have lived longer…experienced much less pain and suffering, and have been able to spend more time with her family.”